ImmunityBio, Inc. (IBRX)

NASDAQ: IBRX · Real-Time Price · USD

2.290

-0.010 (-0.43%)

Dec 5, 2025, 4:00 PM EST - Market closed

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020
United States Revenue	-	14.21M	Log In	Log In	Log In	Upgrade
Europe Revenue	-	531.00K	Log In	Log In	Log In	Upgrade
Revenue (Other)	82.56M	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	82.56M	14.75M	Log In	Log In	Log In	Upgrade

Revenue

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020
Product Revenue	81.92M	14.15M	Log In	Log In	Log In	Upgrade
Other Revenue	639.00K	595.00K	Log In	Log In	Log In	Upgrade
Revenue (Total)	82.56M	14.75M	Log In	Log In	Log In	Upgrade